This announcement is a separate document:
华东医药：关于全资子公司获得美国新药临床试验批准通知书的公告
Huadong Pharmaceutical: Notice on Wholly Owned Subsidiaries Obtaining Approval Notices for Clinical Trials of New Drugs in the US
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.